Debt-to-equity of Esperion Therapeutics, Inc. from 31 Mar 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Esperion Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2014 to 30 Sep 2025.
  • Esperion Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -181%, a 2.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Esperion Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -181% +4% +2.1% 30 Sep 2025
Q2 2025 -182% -5.5% -3.1% 30 Jun 2025
Q1 2025 -187% -20% -12% 31 Mar 2025
Q4 2024 -199% -41% -26% 31 Dec 2024
Q3 2024 -185% -18% -11% 30 Sep 2024
Q2 2024 -177% +2.7% +1.5% 30 Jun 2024
Q1 2024 -168% +23% +12% 31 Mar 2024
Q4 2023 -158% +46% +22% 31 Dec 2023
Q3 2023 -167% +63% +28% 30 Sep 2023
Q2 2023 -179% +35% +16% 30 Jun 2023
Q1 2023 -190% +20% +9.7% 31 Mar 2023
Q4 2022 -204% -1.4% -0.67% 31 Dec 2022
Q3 2022 -230% -20% -9.4% 30 Sep 2022
Q2 2022 -214% +62% +22% 30 Jun 2022
Q1 2022 -211% +337% +62% 31 Mar 2022
Q4 2021 -203% +2043% +91% 31 Dec 2021
Q3 2021 -210% -1631% -115% 30 Sep 2021
Q2 2021 -276% -968% -140% 30 Jun 2021
Q1 2021 -548% -1019% -216% 31 Mar 2021
Q4 2020 -2246% -2404% -1518% 31 Dec 2020
Q3 2020 1420% +1312% +1205% 30 Sep 2020
Q2 2020 692% +625% +926% 30 Jun 2020
Q1 2020 472% +436% +1206% 31 Mar 2020
Q4 2019 158% +130% +455% 31 Dec 2019
Q3 2019 109% +91% +494% 30 Sep 2019
Q2 2019 67% +53% +362% 30 Jun 2019
Q1 2019 36% +22% +149% 31 Mar 2019
Q4 2018 29% +15% +104% 31 Dec 2018
Q3 2018 18% +6% +49% 30 Sep 2018
Q2 2018 15% +5% +52% 30 Jun 2018
Q1 2018 15% +8.4% +136% 31 Mar 2018
Q4 2017 14% +9.7% +227% 31 Dec 2017
Q3 2017 12% +9% +274% 30 Sep 2017
Q2 2017 9.6% +6.4% +201% 30 Jun 2017
Q1 2017 6.1% +3% +94% 31 Mar 2017
Q4 2016 4.3% +1% +30% 31 Dec 2016
Q3 2016 3.3% -0.61% -16% 30 Sep 2016
Q2 2016 3.2% -2% -38% 30 Jun 2016
Q1 2016 3.2% -4.2% -57% 31 Mar 2016
Q4 2015 3.3% -7.6% -70% 31 Dec 2015
Q3 2015 3.9% -7.3% -65% 30 Sep 2015
Q2 2015 5.1% -2.3% -31% 30 Jun 2015
Q1 2015 7.4% -2.7% -27% 31 Mar 2015
Q4 2014 11% 31 Dec 2014
Q3 2014 11% 30 Sep 2014
Q2 2014 7.4% 30 Jun 2014
Q1 2014 10% 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.